Lipidio Pharmaceuticals
Signal active
Organization
Contact Information
Overview
Lipidio Pharmaceuticals is a healthcare company that focuses on advancing a molecule to treat diseases associated with excess body fat. It includes non-alcoholic steatohepatitis, Prader-Willi syndrome, and antipsychotic drug-induced weight gain.
The company was founded in 2018 and headquartered in San Diego, California.
About
Industries
Biotechnology, Health Care, Medical, Biopharma
Founded
2018
Employees
1-10
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Lipidio Pharmaceuticals headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical, Biopharma sector. The company focuses on Biotechnology and has secured $640.0M in funding across 32 round(s). With a team of 1-10 employees, Lipidio Pharmaceuticals is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Lipidio Pharmaceuticals, raised $20.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
2
Investors
2
Lead Investors
0
Total Funding Amount
$20.0M
Details
2
Lipidio Pharmaceuticals has raised a total of $20.0M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2020 | Early Stage Venture | |||
| 2022 | Early Stage Venture | 20.0M |
Investors
Lipidio Pharmaceuticals is funded by 7 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| The Foundation for Prader-Willi Research | - | FUNDING ROUND - The Foundation for Prader-Willi Research | undefined |
| Nancy T. Chang | - | FUNDING ROUND - Nancy T. Chang | 20.0M |
| Lipidio Pharmaceuticals | - | FUNDING ROUND - Lipidio Pharmaceuticals | 20.0M |
| John Maraganore | - | FUNDING ROUND - John Maraganore | 20.0M |
Recent Activity
There is no recent news or activity for this profile.